These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 21030983)
1. Pre-B-cell leukemias in Btk/Slp65-deficient mice arise independently of ongoing V(D)J recombination activity. Ta VB; de Haan AB; de Bruijn MJ; Dingjan GM; Hendriks RW Leukemia; 2011 Jan; 25(1):48-56. PubMed ID: 21030983 [TBL] [Abstract][Full Text] [Related]
2. Highly restricted usage of Ig H chain VH14 family gene segments in Slp65-deficient pre-B cell leukemia in mice. Ta VB; de Bruijn MJ; Matheson L; Zoller M; Bach MP; Wardemann H; Jumaa H; Corcoran A; Hendriks RW J Immunol; 2012 Nov; 189(10):4842-51. PubMed ID: 23066158 [TBL] [Abstract][Full Text] [Related]
3. Malignant transformation of Slp65-deficient pre-B cells involves disruption of the Arf-Mdm2-p53 tumor suppressor pathway. Ta VB; de Bruijn MJ; ter Brugge PJ; van Hamburg JP; Diepstraten HJ; van Loo PF; Kersseboom R; Hendriks RW Blood; 2010 Feb; 115(7):1385-93. PubMed ID: 20008789 [TBL] [Abstract][Full Text] [Related]
4. The BCR-ABL1 kinase bypasses selection for the expression of a pre-B cell receptor in pre-B acute lymphoblastic leukemia cells. Klein F; Feldhahn N; Harder L; Wang H; Wartenberg M; Hofmann WK; Wernet P; Siebert R; Müschen M J Exp Med; 2004 Mar; 199(5):673-85. PubMed ID: 14993251 [TBL] [Abstract][Full Text] [Related]
5. SLP65 deficiency results in perpetual V(D)J recombinase activity in pre-B-lymphoblastic leukemia and B-cell lymphoma cells. Sprangers M; Feldhahn N; Liedtke S; Jumaa H; Siebert R; Müschen M Oncogene; 2006 Aug; 25(37):5180-6. PubMed ID: 16636677 [TBL] [Abstract][Full Text] [Related]
6. Bruton's tyrosine kinase cooperates with the B cell linker protein SLP-65 as a tumor suppressor in Pre-B cells. Kersseboom R; Middendorp S; Dingjan GM; Dahlenborg K; Reth M; Jumaa H; Hendriks RW J Exp Med; 2003 Jul; 198(1):91-8. PubMed ID: 12835482 [TBL] [Abstract][Full Text] [Related]
7. Bruton's tyrosine kinase and SLP-65 regulate pre-B cell differentiation and the induction of Ig light chain gene rearrangement. Kersseboom R; Ta VB; Zijlstra AJ; Middendorp S; Jumaa H; van Loo PF; Hendriks RW J Immunol; 2006 Apr; 176(8):4543-52. PubMed ID: 16585544 [TBL] [Abstract][Full Text] [Related]
8. A truncated heavy chain protein relieves the requirement for surrogate light chains in early B cell development. Shaffer AL; Schlissel MS J Immunol; 1997 Aug; 159(3):1265-75. PubMed ID: 9233622 [TBL] [Abstract][Full Text] [Related]
9. Surface mu heavy chain signals down-regulation of the V(D)J-recombinase machinery in the absence of surrogate light chain components. Galler GR; Mundt C; Parker M; Pelanda R; Mårtensson IL; Winkler TH J Exp Med; 2004 Jun; 199(11):1523-32. PubMed ID: 15173209 [TBL] [Abstract][Full Text] [Related]
10. Deficiency of Bruton's tyrosine kinase in B cell precursor leukemia cells. Feldhahn N; Río P; Soh BN; Liedtke S; Sprangers M; Klein F; Wernet P; Jumaa H; Hofmann WK; Hanenberg H; Rowley JD; Müschen M Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13266-71. PubMed ID: 16141323 [TBL] [Abstract][Full Text] [Related]
11. Bruton's tyrosine kinase regulates the activation of gene rearrangements at the lambda light chain locus in precursor B cells in the mouse. Dingjan GM; Middendorp S; Dahlenborg K; Maas A; Grosveld F; Hendriks RW J Exp Med; 2001 May; 193(10):1169-78. PubMed ID: 11369788 [TBL] [Abstract][Full Text] [Related]
12. Involvement of SLP-65 and Btk in tumor suppression and malignant transformation of pre-B cells. Hendriks RW; Kersseboom R Semin Immunol; 2006 Feb; 18(1):67-76. PubMed ID: 16300960 [TBL] [Abstract][Full Text] [Related]
13. B cell defects in SLP65/BLNK-deficient mice can be partially corrected by the absence of CD22, an inhibitory coreceptor for BCR signaling. Gerlach J; Ghosh S; Jumaa H; Reth M; Wienands J; Chan AC; Nitschke L Eur J Immunol; 2003 Dec; 33(12):3418-26. PubMed ID: 14635051 [TBL] [Abstract][Full Text] [Related]
14. The SRC family kinase LYN redirects B cell receptor signaling in human SLP65-deficient B cell lymphoma cells. Sprangers M; Feldhahn N; Herzog S; Hansmann ML; Reppel M; Hescheler J; Jumaa H; Siebert R; Müschen M Oncogene; 2006 Aug; 25(36):5056-62. PubMed ID: 16568084 [TBL] [Abstract][Full Text] [Related]
15. Bruton's tyrosine kinase is not essential for Bcr-Abl-mediated transformation of lymphoid or myeloid cells. MacPartlin M; Smith AM; Druker BJ; Honigberg LA; Deininger MW Leukemia; 2008 Jul; 22(7):1354-60. PubMed ID: 18548107 [TBL] [Abstract][Full Text] [Related]
16. Surrogate-light-chain silencing is not critical for the limitation of pre-B cell expansion but is for the termination of constitutive signaling. van Loo PF; Dingjan GM; Maas A; Hendriks RW Immunity; 2007 Sep; 27(3):468-80. PubMed ID: 17869135 [TBL] [Abstract][Full Text] [Related]
17. Cellular maturation defects in Bruton's tyrosine kinase-deficient immature B cells are amplified by premature B cell receptor expression and reduced by receptor editing. Middendorp S; Hendriks RW J Immunol; 2004 Feb; 172(3):1371-9. PubMed ID: 14734712 [TBL] [Abstract][Full Text] [Related]
18. Genetic interaction between PARP and DNA-PK in V(D)J recombination and tumorigenesis. Morrison C; Smith GC; Stingl L; Jackson SP; Wagner EF; Wang ZQ Nat Genet; 1997 Dec; 17(4):479-82. PubMed ID: 9398855 [TBL] [Abstract][Full Text] [Related]
20. The absence of SLP65 and Btk blocks B cell development at the preB cell receptor-positive stage. Jumaa H; Mitterer M; Reth M; Nielsen PJ Eur J Immunol; 2001 Jul; 31(7):2164-9. PubMed ID: 11449370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]